In a recent editorial, Guneri & Epstein 3 highlighted clinicians' inability to predict PMD behaviour or quantify the risk of malignant transformation emphasising our poor understanding of carcinogenesis. Contemporary PMD management relies upon incision biopsy for histological confirmation followed by surgical excision for definitive diagnosis and effective treatment of lesions deemed "high risk". [5] [6] [7] Whilst controversy may exist over the assignment of risk, early diagnosis and intervention during the progression of dysplasia to OSCC should have potential to improve patient prognosis and reduce morbidity and mortality; this hypothesis remains largely unproven however. 1 Long-term observational studies of patients with PMD have been advised to improve knowledge of disease progression, to determine predictors of clinical outcome and establish realistic time-scales for malignant transformation. 3, 8 In a previous study, we demonstrated a degree of efficacy for interventional management by reviewing clinical outcome in 590 "high-risk" patients with PMD undergoing CO 2 laser surgery and followed for up to 19 years post-treatment (mean 7.3 years); 438 patients (74.2%) became disease free, 53 (9%) had persistent disease, and 99 (16.8%) developed OSCC. 7 Features associated with malignant transformation included eryrthroleukoplakic appearance, the presence of severe dysplasia in initial biopsies and origin on ventrolateral tongue and floor of mouth sites. 7 The specific purpose of this paper was to re-evaluate the clinicopathological data for these 99 transforming patients with PMD and thereby identify features predictive of cancer, enhance understanding of the carcinogenic pathway and clarify the likely time-course for malignant transformation in patients with PMD. 
| ME TH OD

| RESULTS
Two distinct OSCC presentations were recognised in the 99 patients: 71 were identified immediately and "unexpectedly" upon histopathological assessment of laser excision specimens, whilst 28
cases "progressed" to malignancy at same or new sites during follow-up.
| Unexpected OSCC diagnosis
Data for the 71 "unexpected" OSCC cases are listed in Table 1 Analyses of clinico-pathological variables potentially influencing time to malignancy in the 28 cases are summarised in Table 4 , but none were significant. previous reports and reflective of inherent disease susceptibility. 5, 6, 24 Of clinical relevance is the observation that ventro-lateral tongue and floor of mouth were at particular risk of same-site malignant transformation, both "unexpected" and "progressive", although seemed less likely to be the primary focus in cases of new-site OSCC. Erythroleukoplakia, either as a precursor in "unexpected" cases or as a change in appearance during "progression," was associated with OSCC development, confirming earlier observations and highlighting the importance of its early recognition. 7, 17 Review of precursor histopathology did not show a reliable predictive role, although 52 of 71 "unexpected" (73.2%) and 17 of 28
| DISCUSSION
"progression" cases exhibited severe dysplasia or CiS on initial biopsy, supporting earlier reports regarding high-grade dysplasia risk. 13, 17 Finding micro-invasive cancers in substantive numbers within the "unexpected" group emphasised not only the difficulty in identifying early cancer change clinically, 21 but also the efficacy of intervention via excision because clinical outcome was demonstrably better in these patients. 7 In contrast, despite early recognition during follow-up, the increased number of invasive OSCCs in the "progres- It is the authors' opinion that clarifying terminology will assist future observational studies and therefore advise restricting the term "malignant transformation" to PMDs exhibiting same-site OSCC, whilst distinguishing "cancer development" for those with new-site disease. Intervention to excise localised lesions may indeed prevent or effectively treat "malignant transformation" but the risk of subsequent "cancer development" remains. Active surveillance during patient follow-up is thus an essential component of interventional therapy and allows early signs of further disease to be recognised and treatment initiated.
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The precise interplay of epidemiological, diagnostic, histopathological and bio-molecular factors remains complex, however, with carcinogenesis arising from intrinsic and extrinsic influences acting both synchronously and metachronously throughout ill-defined areas of mucosal field change. 1 Although this was neither a prospective nor randomised controlled trial and was limited in population size from a single-centre, review of clinico-pathological and patient outcome data has provided additional insight into cancer risk within a defined PMD cohort.
Interventional laser surgery facilitates early diagnosis and effective treatment of occult "unexpected" OSCC and reduces morbidity and mortality from same-site transformation, but new-site cancer retains lethality and is a significant long-term risk for all patients with PMD.
